ASTRAZENECA PLC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge
SEC filing record 1 source field available
Fiscal year end
31 December
ASTRAZENECA PLC has filed 2,050 SEC EDGAR filings since 13 Mar 1995

SEC filing history

Showing 401-425 of 1,000 matching filings.

Per page
25
Current page
17
6-K File 001-11960

1ST QUARTER RESULTS

Filing date
27 Apr 2023
Reporting date
27 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

RESULT OF AGM

Filing date
27 Apr 2023
Reporting date
27 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FORM 6-K

Filing date
27 Apr 2023
Reporting date
27 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

BOARD COMMITTEE CHANGES

Filing date
27 Apr 2023
Reporting date
27 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR DECLARATION

Filing date
26 Apr 2023
Reporting date
26 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

UPDATE TO ARRANGEMENTS WITH SOBI AND SANOFI

Filing date
11 Apr 2023
Reporting date
11 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

LYNPARZA + IMFINZI MET ENDPOINT IN OVARIAN CANCER

Filing date
05 Apr 2023
Reporting date
05 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
03 Apr 2023
Reporting date
03 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ULTOMIRIS RECOMMENDED FOR NMOSD EU APPROVAL

Filing date
03 Apr 2023
Reporting date
03 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA COMPLETES KYM AGREEMENT FOR CMG901

Filing date
30 Mar 2023
Reporting date
30 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
27 Mar 2023
Reporting date
27 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FORM 6-K

Filing date
22 Mar 2023
Reporting date
22 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

NOTICE OF AGM

Filing date
22 Mar 2023
Reporting date
22 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-11960

CERT filing

Filing date
15 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-11960

8-A12B

Filing date
13 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

IMFINZI IMPROVED EFS IN RESECTABLE LUNG CANCER

Filing date
09 Mar 2023
Reporting date
09 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
08 Mar 2023
Reporting date
08 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

DIRECTOR/PDMR SHAREHOLDING

Filing date
08 Mar 2023
Reporting date
08 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ENHERTU DESTINY-PANTUMOR02 SHOWS POSITIVE RESULTS

Filing date
06 Mar 2023
Reporting date
06 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

FORM 6-K

Filing date
03 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B2 File 333-256406

424B2

Filing date
02 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

TOTAL VOTING RIGHTS

Filing date
01 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-11960

ASTRAZENECA PRICES A $2.25BN BOND OFFERING

Filing date
01 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-256406

FWP

Filing date
01 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B2 File 333-256406

424B2

Filing date
28 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .